|
|
|
|
LEADER |
01000caa a2200265 4500 |
001 |
OLC1964461448 |
003 |
DE-627 |
005 |
20220215173910.0 |
007 |
tu |
008 |
160206s2015 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a PQ20160617
|
035 |
|
|
|a (DE-627)OLC1964461448
|
035 |
|
|
|a (DE-599)GBVOLC1964461448
|
035 |
|
|
|a (PRQ)p835-1544d256be68382d4021a3163557cabf598e0a4311d0186a3026dba3716f2d30
|
035 |
|
|
|a (KEY)0031125120150000078000100026clinicalandscientificaspectsrelatedtobiosimilarsin
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
4 |
|a 610
|q DNB
|
084 |
|
|
|a 44.00
|2 bkl
|
100 |
1 |
|
|a Vermeire, S
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)
|
264 |
|
1 |
|c 2015
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
700 |
1 |
|
|a Louis, E
|4 oth
|
700 |
1 |
|
|a Dewit, O
|4 oth
|
700 |
1 |
|
|a Franchimont, D
|4 oth
|
700 |
1 |
|
|a Moreels, T
|4 oth
|
700 |
1 |
|
|a Ferrante, M
|4 oth
|
700 |
1 |
|
|a Rahier, J-F
|4 oth
|
700 |
1 |
|
|a Van Hootegem, Ph
|4 oth
|
700 |
1 |
|
|a De Vos, M
|4 oth
|
700 |
1 |
|
|a Mana, F
|4 oth
|
700 |
1 |
|
|a Baert, F
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|t Acta gastro-enterologica Belgica
|d Bruxelles, 1946
|g 78(2015), 1, Seite 26
|w (DE-627)16620241X
|w (DE-600)127060-6
|w (DE-576)014522179
|x 0001-5644
|7 nnns
|
773 |
1 |
8 |
|g volume:78
|g year:2015
|g number:1
|g pages:26
|
856 |
4 |
2 |
|u http://www.ncbi.nlm.nih.gov/pubmed/26118575
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_OLC
|
912 |
|
|
|a GBV_ILN_4012
|
912 |
|
|
|a GBV_ILN_4219
|
936 |
b |
k |
|a 44.00
|q AVZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 78
|j 2015
|e 1
|h 26
|